1. CATEGORIES OF ARTICLES
The Rinsho Hyoka accepts submissions of manuscripts categorized as originals, reviews, opinions, commentaries, materials. Originals, reviews, opinions should not have been published or submitted to any other journal for publication.2. REVIEW AND ACCEPTANCE OF SUBMISSIONS
All manuscripts are peer reviewed by a group of experts before being accepted for publication. Authors/contributors of such manuscripts may be asked to modify or amend the submitted manuscript during the review process.3. MANUSCRIPT PREPARATION
1) Articles or contributions may be submitted either in the Japanese or the English language.2) The Title Page must contain the following:
3) Provide a separate page for abstract written in Japanese and in English. In the case of original and review, "structured abstract" has to be used. The structured abstract of original, in principle, should containe; Objective, Design, Methods, Results, and Conclusion.
- Title (In Japanese and English. If the study design is randomized controlled trial (RCT), this should be specifically stated in the title).
- Key Words (Provide five (5) key words written in English. In case of RCT, provide the name of the test drug and the controlled drug used in the study, and RCT).
- Author's Name (In Japanese and English)
- Affiliation of authors(In Japanese and English)
4) All manuscripts should, in principle, follow the following format or order: Introduction, Methods, Results, Consideration, Conclusion, Acknowledgement (if necessary), and References,in this order. In case of RCT, the format of reporting should follow the CONSORT statement.
5) Include brief title for each figure, table, photograph and other illustration used in the article. The title of these should be written in English. Figures, Tables, and pictures should be clear and large enough to remain legible after the figure has been reduced to fit a boxed portion in the journal page. Provide a separate page for legends/explanations for these figures and illustrations written in English.
6) The first time that an abbreviation appear, it should be followed by the words or term for which it stands. Units of measurements should, in principle, follow the International System of Units (SI).
7) Persons' names appearing in the articles should, in principle, be written in the original language. The names of drugs should be expressed in generic terms (small letters in English). At the first appearance of the generic name, it should be followed by the trade/brand names following by the registered trademarkR (Example: haloperidol (SerenaceR); etidronate disodim (Didronel R)).
8) The reference listings should be double-spaced and numbered consecutively as they are quoted. References cited in tables and figures must also be numbered in the reference list. The style of references should follow the Vancouver Style. List all authors when there are six or fewer; when there are seven or more authors, list the first three authors, followed by "et al." The following are samples of references:
In case of Journal Reference:
Example 1: Sato T, Yoshimura I. Expectations for an international harmonized guideline. Drug Information Journal 1998; 32 : 135-9.
Example 2: Tsubaki H, Fujita T, Satoh Y. Darega tameno rinsho tokei? Waga kuni de zissen sareta "Kanja no tachiba karano" rinsho hyoka no gensoku to tokeiteki hoho no yakuwari (Historical remarks on the patient oriented clinical evaluation in Japan and its statistical aspects). Tokei Suri (Proceedings of the Institute of Statistical Mathematics) 1998; 46: 97-115 (in Japanese).In case of Book Reference:
Example 1: Meinert Cl, Tonascia S. Clinical trials; Design, Conduct, and Analysis. New York: Oxford University Press; 1986.
Example 2: Nagoh N. Ebidensu to rinsho no genba (Evidence and clinical practice). In: Tsutani K, Shimizu N, eds. Iyakuhin Tekiogai Shiyo no Ebidensu (Evidence of Off-Label Use of Drug). Digital Press; 1999: 221-43 (in Japanese).9) In case the manuscript includes materials or quotations taken from published sources, a written statement or certificate allowing publication the Rinsho Hyoka must be attached to the manuscript.
10) Financial associations or support for a study must be disclosed in the form of a written statement submitted by the authors to the editors. In the case of clinical trials, the name of the sponsor-company, the controllers and the statistical analysis institution must be stated. The authors may also undertake to provide data or cooperate with the editors in obtaining materials or data to ensure the reliability of the manuscript.
11) Authors must submit the original manuscript and two (2) copies thereof in typewritten/printed in standard-sized paper. All manuscripts are non-returnable unless the authors request in advance. If the manuscript is accepted for publication, the authors will be asked to supply a file copy on a diskette in ASCII Text, MS Word , or TEX formats. The name of the word processing machine used should also be mentioned when it is used.
4. REMUNERATION AND PUBLICATION FEE
1) The Rinsho Hyoka shall, in principle, pay for manuscripts of original reports of negative trials, reports on adverse drug reactions (ADR) and adverse event (AE) and other original articles relating to clinical studies such as opinions, reviews, commentaries, and materials.2) For all other categories of original articles, the authors should pay for the publication.
3) Request for publication of extra illustrations must be paid for by the authors.
5. MANUSCRIPT SUBMISSION.
All manuscripts should be sent by registered mail to the following ;
Editor, Rinsho Hyoka (Clinical Evaluation)
Sato-jitsugyo Ebisu Bldg.4F,1-11-2, Ebisu, Shibuya-ku,
Tokyo 150-0013, Japan
tel: +81-3-5475-1690, fax: +81-3-5475-1675
e-mail: cont@nifty.com
URL: http://homepage3.nifty.com/cont/REFERENCES
- Haynes RB, Mulrow CD, Huth EJ, Altman DG, Gardner MJ. More informative abstracts revisited. Ann Intern Med 1990 ; 113(1): 69-76.
- Aoki M. Structured Abstracts no yukosei (Usefulness of structured abstracts). Igaku Tosyokan 1995; 42(3): 317-24 (in Japanese).
- Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials The CONSORT Statement. JAMA 1996; 276(8): 637-9.【Tsutani K, Kojima C, tr. Musakuika hikaku shiken no hokoku no shitsu wo kaizen suru hoho CONSORT seimei. JAMA <Nihongo ban> 1997nen 7gatsu go: 74-7 (in Japanese)】.
- International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals. Ann Intern Med 1997; 126: 36-47.【Various Instructions for Authors including Vancouver Style can be found in the following Website ; http://www.mco.edu/lib/instr/libinsta.html】
- Yoshida K, Yamazaki Y. "Seibutsu igaku zasshi ni kansuru toitsu kitei" no kaitei (1) (Uniform requirements for manuscripts submitted to biomedical journals, Fifth edition). Igaku no Ayumi 1998; 186(11): 812-4 (in Japanese).
- Yoshida K, Yamazaki Y. "Seibutsu igaku zasshi ni kansuru toitsu kitei" no kaitei (2) (Uniform requirements for manuscripts submitted to biomedical journals, Fifth edition). Igaku no Ayumi 1998; 186(12): 872-9 (in Japanese).
Instruction for authors
the first edition Apr.1974
the second edition Oct.1981
the third edition Apr.1984
the forth edition (homepage version) Sep.1999